UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 8,400	$ 7,405
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	395	330
Amortization	1,128	1,031
(Gain) on investments	(32)	0
Provision for (recovery of) losses on accounts receivable	1	(1)
(Gain)/Loss on disposal of assets	(418)	0
Deferred income taxes	(225)	(182)
Stock-based compensation expense	42	69
Tax benefit attributable to exercise of stock options	39	21
Changes in operating assets and liabilities:
Accounts receivable	(992)	(1,157)
Accrued interest and other receivables	0	(5)
Inventories	(45)	(100)
Prepaid expenses and other current assets	(3)	60
Accounts payable	51	68
Accrued expenses	(594)	203
Total adjustments	(653)	337
Net cash provided by operating activities	7,747	7,742
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures for property and equipment	(201)	(114)
Capital expenditures for intangible assets	0	0
Purchases of investments	0	0
Proceeds from sale of investments	74	0
Proceeds from sale of property and equipment	862	0
Net cash provided by (used in) investing activities	735	(114)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	347	168
Payment of dividends	(2,011)	(984)
Net cash provided by (used in) financing activities	(1,664)	(816)
Effect of exchange rate changes on cash	(820)	629
Net increase (decrease) in cash and cash equivalents	5,998	7,441
Cash at beginning of period	39,875	26,296
Cash at end of period	45,873	33,737
Cash paid during the period for income taxes	3,016	2,676
Cash paid during the period for interest	$ 0	$ 0